Enzymotec Ltd. to Report Second Quarter Fiscal Year 2014 Financial Results
July 24 2014 - 4:05PM
Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid ingredients, today
announced that it will release financial results for the second
quarter ended June 30, 2014 on Tuesday, August 5, 2014, before the
market opens. Following the release, the Company will host a
conference call to discuss these results with additional comments
and details. Participating on the call will be Dr. Ariel Katz,
President and Chief Executive Officer, and Oren Bryan, Vice
President and Chief Financial Officer.
The conference call is scheduled to begin at 8:30 a.m. ET on
Tuesday, August 5, 2014. Listeners in North America may dial
877-359-9508 and international listeners may dial 224-357-2393
along with confirmation code 78146190 to access the live call. A
telephonic playback will be available after the call through
Tuesday, August 12, 2014. Participants in North America may dial
855-859-2056 and international participants may dial 404-537-3406
along with the confirmation code 78146190 to hear the playback.
The call will also be broadcast live over the Internet, hosted
at the Investors section of Enzymotec's website at
http://ir.enzymotec.com, and will be archived online within one
hour of its completion through Tuesday, August 12, 2014.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based
products and solutions. The Company develops, manufactures and
markets innovative bio-active lipid ingredients, as well as final
products, based on sophisticated processes and technologies. For
more information, visit www.enzymotec.com.
CONTACT: ICR
Katie Turner
646-277-1228
Katie.Turner@icrinc.com
John Mills
310-954-1105
John.Mills@icrinc.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024